---
title: "Healthgen Biotechnology (688765.SH) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/688765.SH/norm.md"
symbol: "688765.SH"
name: "Healthgen Biotechnology"
parent: "https://longbridge.com/zh-CN/quote/688765.SH.md"
datetime: "2026-03-17T08:15:06.776Z"
locales:
  - [en](https://longbridge.com/en/quote/688765.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688765.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688765.SH/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/688765.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688765.SH/norm.md)


# Healthgen Biotechnology (688765.SH) — 财务报表

## 利润表 (CNY)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1525 | -0.1500 | -0.1500 | -0.1350 | -0.1268 |
| ROE | -30.85% | -30.75% | - | -24.20% | -20.01% |
| Revenue | 6.95M | 6.36M | 6.36M | 7.84M | 11.96M |
| Net income | -39.64M | -40.81M | -40.81M | -36.39M | -33.24M |
| Operating income | -30.05M | -44.86M | -44.86M | -29.00M | -19.73M |
| Gross margin | 39.83% | 55.69% | 55.69% | 68.60% | 73.61% |
| Net margin | -570.38% | -642.21% | -642.21% | -464.06% | -278.00% |
| Profit quality | - | - | - | - | - |

## 资产负债表 (CNY)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.46B | 1.32B | 1.32B | 1.06B | - |
| Leverage | 2.95 | 2.48 | 2.48 | 1.77 | - |
| BVPS | 1.85 | 1.98 | 1.98 | 2.23 | 2.48 |
| Turnover | - | - | - | 0.0249 | - |
| Cash & STI | 74.82M | 132.37M | 132.37M | 160.40M | 162.75M |
| Inv & Rec | 105.95M | 80.63M | 80.63M | 50.02M | - |
| LT assets | 961.18M | 841.20M | 841.20M | 733.42M | - |
| Net debt | 531.85M | 400.92M | 400.92M | 52.89M | -21.18M |

## 现金流量表 (CNY)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -62.87M | -28.00M | -28.00M | -8.55M | -12.26M |
| Investing CF | -62.60M | -134.50M | -134.50M | -33.10M | -51.87M |
| Financing CF | 67.90M | 148.51M | 148.51M | 40.48M | 48.92M |
| Free CF | -64.25M | -140.60M | - | -71.86M | - |
| OCF coverage | -72.91% | -20.08% | -20.08% | -23.80% | -22.90% |
| Repaid & issued | 92.33M | 157.13M | 157.13M | 43.39M | 50.81M |
| CapEx | -62.60M | -134.50M | -134.50M | -33.10M | -51.87M |